Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo
作者： Zhiyun Yu , Gang Zhao , Guifang Xie , Liyan Zhao , Yong Chen
关键词:
摘要: Glioblastoma (GBM) is the most frequent and aggressive brain tumor in adults. In spite of advances in diagnosis and therapy, the prognosis of patients with GBM has remained dismal. …
impactjournals.com参考文章(42)
RE Kast, G Karpel-Massler, M-E Halatsch, Can the therapeutic effects of temozolomide be potentiated by stimulating AMP-activated protein kinase with olanzepine and metformin? British Journal of Pharmacology. ,vol. 164, pp. 1393- 1396 ,(2011) , 10.1111/J.1476-5381.2011.01320.X
Alfonso Bellacosa, C. Chandra Kumar, Antonio Di Cristofano, Joseph Robert Testa, Activation of AKT kinases in cancer: implications for therapeutic targeting. Advances in Cancer Research. ,vol. 94, pp. 29- 86 ,(2005) , 10.1016/S0065-230X(05)94002-5
Roberto Würth, Alessandra Pattarozzi, Monica Gatti, Adirana Bajetto, Alessandro Corsaro, Alessia Parodi, Rodolfo Sirito, Michela Massollo, Cecilia Marini, Gianluigi Zona, Daniela Fenoglio, Gianmario Sambuceti, Gilberto Filaci, Antonio Daga, Federica Barbieri, Tullio Florio, Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt. Cell Cycle. ,vol. 12, pp. 145- 156 ,(2013) , 10.4161/CC.23050
Marta Gritti, Roberto Würth, Marina Angelini, Federica Barbieri, Marta Peretti, Erika Pizzi, Alessandra Pattarozzi, Elisa Carra, Rodolfo Sirito, Antonio Daga, Paul M.G. Curmi, Michele Mazzanti, Tullio Florio, Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current Oncotarget. ,vol. 5, pp. 11252- 11268 ,(2014) , 10.18632/ONCOTARGET.2617
Christine E. Eyler, Wen-Chi Foo, Katherine M. LaFiura, Roger E. McLendon, Anita B. Hjelmeland, Jeremy N. Rich, Brain Cancer Stem Cells Display Preferential Sensitivity to Akt Inhibition Stem Cells. ,vol. 26, pp. 3027- 3036 ,(2008) , 10.1634/STEMCELLS.2007-1073
Zhiyun Yu, Guifang Xie, Guangtong Zhou, Ye Cheng, Guangtao Zhang, Guangming Yao, Yong Chen, Yunqian Li, Gang Zhao, NVP-BEZ235, a novel dual PI3K–mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells Cancer Letters. ,vol. 367, pp. 58- 68 ,(2015) , 10.1016/J.CANLET.2015.07.007
Jennifer R. Molina, Yuho Hayashi, Clifton Stephens, Maria-Magdalena Georgescu, Invasive glioblastoma cells acquire stemness and increased Akt activation. Neoplasia. ,vol. 12, pp. 453- 463 ,(2010) , 10.1593/NEO.10126
Mahvash Zakikhani, Marie-José Blouin, Esther Piura, Michael N. Pollak, Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells Breast Cancer Research and Treatment. ,vol. 123, pp. 271- 279 ,(2010) , 10.1007/S10549-010-0763-9
Maria De Salvo, Giovanna Maresca, Igea D'agnano, Rodolfo Marchese, Antonio Stigliano, Raffaella Gagliassi, Ercole Brunetti, Giorgio H. Raza, Ugo De Paula, Barbara Bucci, Temozolomide induced c-Myc-mediated apoptosis via Akt signalling in MGMT expressing glioblastoma cells International Journal of Radiation Biology. ,vol. 87, pp. 518- 533 ,(2011) , 10.3109/09553002.2011.556173
A Eramo, L Ricci-Vitiani, A Zeuner, R Pallini, F Lotti, G Sette, E Pilozzi, L M Larocca, C Peschle, R De Maria, Chemotherapy resistance of glioblastoma stem cells Cell Death & Differentiation. ,vol. 13, pp. 1238- 1241 ,(2006) , 10.1038/SJ.CDD.4401872